Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Correlation of VEGF, HIF-1α, and Glucose Metabolism in the Development of Retinopathy of Prematurity
Author Affiliations & Notes
  • Julianna Santos
    Ophthalmology, Texas Tech University Health Sciences Center, Lubbock, Texas, United States
  • Amanda Tijerina
    UMC Hospital, Texas, United States
  • Lingkun Kong
    Ophthalmology, Texas Tech University Health Sciences Center, Lubbock, Texas, United States
  • Footnotes
    Commercial Relationships   Julianna Santos, None; Amanda Tijerina, None; Lingkun Kong, None
  • Footnotes
    Support  Internal Support
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 2182. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Julianna Santos, Amanda Tijerina, Lingkun Kong; Correlation of VEGF, HIF-1α, and Glucose Metabolism in the Development of Retinopathy of Prematurity. Invest. Ophthalmol. Vis. Sci. 2020;61(7):2182.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Premature infants can develop several complications including ROP and hyperglycemia. Hyperglycemia is usually associated with morbidity and mortality including other complications. We hypothesize that the glucose metabolism which is regulated by the hypoxia inducible factor -1α (HIF-1α) and hyperglycemia plays an important role in the development of ROP.

Methods : This study is approved by the Texas Tech University Health Sciences Center (TTUHSC) IRB. The plasma samples were obtained from the clinical lab of hospital. Twenty-seven infants were included in this study, 14 were born at gestational age (GA) less than 32 weeks (high risk for ROP) and 13 were born at more than 32 GA (low risk for ROP). The blood glucose levels were collected from the medical record. Glycolytic products pyruvate and lactate were measured using colorimetric assays kits. HIF-1α and VEGF levels were measured by their respective Human ELISA Assay Kits. The data was analyzed using GraphPad Prism 8 Software. Plasma levels of these factors at 33 PMA were compared between high and low risk groups by student t and f test. Statistical significance was set <0.05.

Results : The glucose levels were higher in high risk for ROP group (less than 32 weeks GA) compared to low risk infants (29 weeks 110.7 ±4.13, 30 weeks 89.21 ±4.67, 32 weeks 82.90±2.56, 38 weeks 65.36 ±1.81, and 40 weeks 66.02 ±1.54 mg/dL, comparisons between 29,30, and 32 vs 40 p<0.0001 and comparison between 38 vs 40 weeks p=0.77). At 33 weeks PMA, there were no significant differences in VEGF ( 588.2±199.0 vs 229.7±445.0, pg/mL, p=0.46), HIF-1α ( 1862.8 ± 782.6 vs 1910.8 ±1237.4, pg/mL, p=0.90), blood glucose levels ( 82.5 ± 7.8 vs 66.2 ± 5.5, mg/dL, p=0.089), and lactate levels ( 8.6 ± 0.6 vs 8.4 ± 1.2, mM, p=0.89), respectively for high risk and low risk infants. The pyruvate level in high risk infants was significantly higher than in low risk infants ( 13.2 ±2.1 vs 0.4 ±4.3, nmol, p=0.007).

Conclusions : Low gestational age infants at high risk for ROP have hyperglycemia from birth. The high levels of pyruvate are directly associated to the high rate of glucose metabolism. The pathophysiology mechanism of ROP remains to be established and due to the hypoxic environment caused by the disease development. Our data suggests that glucose metabolism plays an important in the development of ROP.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×